Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
73.9M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
42.5M
-
Shares change
-
+430K
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$1.46M
-
Number of buys
-
47
-
Number of sells
-
-37
-
Price
-
$3.43
Significant Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q3 2025
112 filings reported holding CATX - Perspective Therapeutics, Inc. - COMMON STOCK as of Q3 2025.
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.5M shares
of 73.9M outstanding shares and own 57.51% of the company stock.
Largest 10 shareholders include FMR LLC (10M shares), BlackRock, Inc. (4.37M shares), VANGUARD GROUP INC (3.44M shares), Avidity Partners Management LP (2.99M shares), MORGAN STANLEY (2.76M shares), MILLENNIUM MANAGEMENT LLC (2.56M shares), Nicholson Wealth Management Group, LLC (1.62M shares), GEODE CAPITAL MANAGEMENT, LLC (1.43M shares), Nuveen, LLC (1.31M shares), and STATE STREET CORP (1.1M shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.